Research Projects

  • General
    Alzheimer´s Disease (AD) is a heterogenous disease from pathophysiological aspects. Clinical form of this disorder develops on the basis of various factors interactions. The deepening of degenerative neuronal damage (especially dendrites), their synaptic connections and cortico-subcortical atrophy induces memory loss and communication skills, psychosis, and after 3-7 years leads to death. The mechanism of neuronal death, respectively initiation mechanism of death are not yet known.
  • Access of Group
    At present time, only the use of cholinesterase inhibitors and NMDA receptor antagonists in the treatment of Alzheimer´s disease (AD) is justified from the Evidence Based Medicine (EBM) point of view.

© 2017 Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic
Website information | Powered by Kentico